260 related articles for article (PubMed ID: 34490707)
1. Comparison of the efficacy and safety of minocycline and clofazimine in chronic and recurrent erythema nodosum leprosum-A randomized clinical trial.
Hanumanthu V; Thakur V; Narang T; Dogra S
Dermatol Ther; 2021 Nov; 34(6):e15125. PubMed ID: 34490707
[TBL] [Abstract][Full Text] [Related]
2. Thalidomide and steroid in the management of erythema nodosum leprosum.
P K Mishra SR; Samal R; Behera B
Indian J Pharmacol; 2022; 54(3):177-182. PubMed ID: 35848688
[TBL] [Abstract][Full Text] [Related]
3. Interventions for erythema nodosum leprosum.
Van Veen NH; Lockwood DN; van Brakel WH; Ramirez J; Richardus JH
Cochrane Database Syst Rev; 2009 Jul; (3):CD006949. PubMed ID: 19588412
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Efficacy and Safety of Ciclosporin to Prednisolone in the Treatment of Erythema Nodosum Leprosum: Two Randomised, Double Blind, Controlled Pilot Studies in Ethiopia.
Lambert SM; Nigusse SD; Alembo DT; Walker SL; Nicholls PG; Idriss MH; Yamuah LK; Lockwood DN
PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004149. PubMed ID: 26919207
[TBL] [Abstract][Full Text] [Related]
5. Does clofazimine prevent erythema nodosum leprosum (ENL) in leprosy? A retrospective study, comparing the experience of multibacillary patients receiving either 12 or 24 months WHO-MDT.
Balagon M; Saunderson PR; Gelber RH
Lepr Rev; 2011 Sep; 82(3):213-21. PubMed ID: 22125929
[TBL] [Abstract][Full Text] [Related]
6. International workshop on erythema nodosum leprosum (ENL)--consensus report; the formation of ENLIST, the ENL international study group.
Walker SL; Saunderson P; Kahawita IP; Lockwood DN
Lepr Rev; 2012 Dec; 83(4):396-407. PubMed ID: 23614260
[No Abstract] [Full Text] [Related]
7. Methotrexate and prednisolone study in erythema nodosum leprosum (MaPs in ENL) protocol: a double-blind randomised clinical trial.
de Barros B; Lambert SM; Shah M; Pai VV; Darlong J; Rozario BJ; Alinda MD; Sales AM; Doni S; Hagge DA; Shrestha D; Listiawan MY; Yitaye AM; Nery JAC; Neupane KD; Dias VLA; Butlin CR; Nicholls PG; Lockwood D; Walker SL
BMJ Open; 2020 Nov; 10(11):e037700. PubMed ID: 33203627
[TBL] [Abstract][Full Text] [Related]
8. [Pentoxifylline in the treatment of erythema nodosum leprosum: results of an open study].
de Carsalade GY; Achirafi A; Flageul B
Acta Leprol; 2003; 12(3):117-22. PubMed ID: 15040702
[TBL] [Abstract][Full Text] [Related]
9. Case Report: Rapid Response to Low-Dose Thalidomide in a Case of Severe Steroid Recalcitrant Erythema Nodosum Leprosum.
Savitha B; Sardana K; Kumari R; Khurana A; Sinha S; Sachdeva S
Am J Trop Med Hyg; 2021 Oct; 106(1):51-53. PubMed ID: 34662871
[TBL] [Abstract][Full Text] [Related]
10. Role of azathioprine in preventing recurrences in a patient of recurrent erythema nodosum leprosum.
Verma KK; Srivastava P; Minz A; Verma K
Lepr Rev; 2006 Sep; 77(3):225-9. PubMed ID: 17172003
[TBL] [Abstract][Full Text] [Related]
11. Pulsed corticosteroid therapy in patients with chronic recurrent ENL: a pilot study.
Girdhar A; Chakma JK; Girdhar BK
Indian J Lepr; 2002; 74(3):233-6. PubMed ID: 12708702
[TBL] [Abstract][Full Text] [Related]
12. A real-world study of low-dose thalidomide in severe erythema nodosum leprosum highlighting its mechanistic rationale in a resource-constrained target population.
Bathula S; Sardana K; Mathachan SR; Khurana A; Ahuja A; Paliwal P
Int J Dermatol; 2023 Jan; 62(1):48-55. PubMed ID: 35924464
[TBL] [Abstract][Full Text] [Related]
13. Interventions for erythema nodosum leprosum. A Cochrane review.
Van Veen NH; Lockwood DN; Van Brakel WH; Ramirez J; Richardus JH
Lepr Rev; 2009 Dec; 80(4):355-72. PubMed ID: 20306635
[TBL] [Abstract][Full Text] [Related]
14. Using methotrexate to treat patients with ENL unresponsive to steroids and clofazimine: a report on 9 patients.
Hossain D
Lepr Rev; 2013 Mar; 84(1):105-12. PubMed ID: 23741889
[TBL] [Abstract][Full Text] [Related]
15. Erythema Nodosum Leprosum: Update and challenges on the treatment of a neglected condition.
Costa PDSS; Fraga LR; Kowalski TW; Daxbacher ELR; Schuler-Faccini L; Vianna FSL
Acta Trop; 2018 Jul; 183():134-141. PubMed ID: 29474830
[TBL] [Abstract][Full Text] [Related]
16. Chronic recurrent ENL, steroid dependent: long-term treatment with high dose clofazimine.
Schreuder PA; Naafs B
Lepr Rev; 2003 Dec; 74(4):386-9. PubMed ID: 14750585
[No Abstract] [Full Text] [Related]
17. Thalidomide in the treatment of erythema nodosum leprosum (ENL) in an outpatient setting: A five-year retrospective analysis from a leprosy referral centre in India.
Upputuri B; Pallapati MS; Tarwater P; Srikantam A
PLoS Negl Trop Dis; 2020 Oct; 14(10):e0008678. PubMed ID: 33035210
[TBL] [Abstract][Full Text] [Related]
18. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
[TBL] [Abstract][Full Text] [Related]
19. Erythema nodosum leprosum in Nepal: a retrospective study of clinical features and response to treatment with prednisolone or thalidomide.
Feuth M; Brandsma JW; Faber WR; Bhattarai B; Feuth T; Anderson AM
Lepr Rev; 2008 Sep; 79(3):254-69. PubMed ID: 19009975
[TBL] [Abstract][Full Text] [Related]
20. Minocycline for Recurrent and/or Chronic Erythema Nodosum Leprosum.
Narang T; Sawatkar GU; Kumaran MS; Dogra S
JAMA Dermatol; 2015 Sep; 151(9):1026-8. PubMed ID: 25874961
[No Abstract] [Full Text] [Related]
[Next] [New Search]
